PALIPERIDONE PALMITATE | N022264 | JANSSEN PHARMACEUTICALS INC
| Trial # | Patent | Type | Petitioner | Status | Filed | Decision |
|---|---|---|---|---|---|---|
| IPR2020-00440 | 9439906 | IPR | Mylan Laboratories Ltd. et al. | Institution Denied | 2020-02-07 | — |
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
JANSSEN PHARMACEUTICALS, INC et al v. EUGIA PHARMA SPECIALTIES LTD. et al 1 patentANDA 221305paliperidone palmitate extended-release injectable suspension | D.N.J. | 2026-03-25 | Active | — |
Janssen Pharmaceuticals, Inc. et al v. Sun Pharmaceutical Industries Ltd. et al 1 patentANDA 217818paliperidone palmitate | D. Del. | 2025-07-10 | Terminated 2025-10-28 | — |
JANSSEN PHARMACEUTICALS, INC et al v. SUN PHARMACEUTICAL INDUSTRIES LTD. et al 1 patentANDA 217818paliperidone palmitate extended-release injectable suspension | D.N.J. | 2025-07-09 | Terminated 2025-12-29 | — |
JANSSEN PHARMACEUTICALS, INC. et al v. ACCORD HEALTHCARE, INC. 1 patentANDA 216674paliperidone palmitate extended-release injectable suspension | D.N.J. | 2022-02-16 | Terminated 2022-07-13 | — |
Janssen Pharmaceuticals, Inc., et al. v. Tolmar, Inc. 1 patentANDA 211995paliperidone palmitate extended-release injectable suspension | D. Del. | 2021-12-21 | Terminated 2024-03-13 | — |
JANSSEN PHARMACEUTICALS, INC et al v. PHARMASCIENCE INC. et al 1 patentANDA 210397paliperidone palmitate | D.N.J. | 2019-12-19 | Terminated 2022-07-13 | — |
Janssen Pharmaceuticals, Inc. et al v. Mylan Laboratories Limited et al 1 patentANDA 213124paliperidone palmitate extended-release injectable suspension | D. Del. | 2019-08-09 | Terminated 2019-09-27 | — |
JANSSEN PHARMACEUTICALS, INC. et al v. MYLAN LABORATORIES LIMITED et al 1 patentANDA 213124paliperidone palmitate | D.N.J. | 2019-08-08 | Terminated 2021-12-22 | — |
JANSSEN PHARMACEUTICALS, INC. et al v. TEVA PHARMACEUTICALS USA, INC. et al 1 patentANDA 211149paliperidone palmitate extended release injectable suspension | D.N.J. | 2018-01-17 | Terminated 2021-11-16 | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).
| Patent # | Expiration | PED | Drug Substance | Drug Product | Use Code | Delist |
|---|---|---|---|---|---|---|
| 9439906 | Jan 26, 2031 | — | — | — | — |